BackgroundPost-term pregnancies have increased risks for adverse fetal and maternal outcomes. Maternal concentrations of the placenta-associated proteins placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) have been identified as predictors for preeclampsia and fetal growth restriction, both syndromes of placental dysfunction. We have proposed that low maternal circulating PlGF and increased sFlt-1 are general markers for syncytiotrophoblast stress, which increases at and beyond term, even in apparently uncomplicated pregnancies. Our aim was to establish circulating PlGF, sFlt-1, and sFlt-1/PlGF reference ranges in healthy post-term pregnancies (gestational week ≥40+2), comparing with healthy term pregnancies and ...
Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng...
Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng...
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevat...
Background Post-term pregnancies have increased risks for adverse fetal and maternal outcomes. Mate...
Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) contribute in the dev...
Abstract Background Fetal growth restriction is a disorder of placental dysfunction with three to fo...
To assess the association of a serum soluble fms-like tyrosine kinase 1-to-placental growth factor (...
BACKGROUND: Fetal growth restriction is a disorder of placental dysfunction with three to four-fold ...
There is little knowledge about the significance of extremely high values (>655) for the ratio of lt...
There is little knowledge about the significance of extremely high values (>655) for the ratio of lt...
BACKGROUND: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble en...
Background The angiogenic factors soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth f...
Introduction The objectives of this study were to describe the histo-morphology of post-date placen...
The objective: to evaluate the clinical and prognostic value and meaning of the ratio of the anti-an...
Background The angiogenic factors soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth f...
Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng...
Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng...
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevat...
Background Post-term pregnancies have increased risks for adverse fetal and maternal outcomes. Mate...
Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) contribute in the dev...
Abstract Background Fetal growth restriction is a disorder of placental dysfunction with three to fo...
To assess the association of a serum soluble fms-like tyrosine kinase 1-to-placental growth factor (...
BACKGROUND: Fetal growth restriction is a disorder of placental dysfunction with three to four-fold ...
There is little knowledge about the significance of extremely high values (>655) for the ratio of lt...
There is little knowledge about the significance of extremely high values (>655) for the ratio of lt...
BACKGROUND: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble en...
Background The angiogenic factors soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth f...
Introduction The objectives of this study were to describe the histo-morphology of post-date placen...
The objective: to evaluate the clinical and prognostic value and meaning of the ratio of the anti-an...
Background The angiogenic factors soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth f...
Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng...
Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng...
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevat...